A citation-based method for searching scientific literature

Mark G Kris, Bruce E Johnson, Lynne D Berry, David J Kwiatkowski, A John Iafrate, Ignacio I Wistuba, Marileila Varella-Garcia, Wilbur A Franklin, Samuel L Aronson, Pei-Fang Su, Yu Shyr, D Ross Camidge, Lecia V Sequist, Bonnie S Glisson, Fadlo R Khuri, Edward B Garon, William Pao, Charles Rudin, Joan Schiller, Eric B Haura, Mark Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D Minna, Paul A Bunn. JAMA 2014
Times Cited: 955



Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn, Margarita Majem, Mary J Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled-Filhart, Edward B Garon. Lancet 2016
Times Cited: 3479




List of shared articles



Times cited

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer.
Monika Pradhan, Mathieu Chocry, Don L Gibbons, Boris Sepesi, Tina Cascone. Transl Lung Cancer Res 2021
4

Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with Lung Adenocarcinoma with EGFR Exon 20 Insertions.
Noura J Choudhury, Adam J Schoenfeld, Jessica Flynn, Christina J Falcon, Hira Rizvi, Charles M Rudin, Mark G Kris, Maria E Arcila, Glenn Heller, Helena A Yu,[...]. Clin Cancer Res 2021
4

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study.
Krittiya Korphaisarn, Pongwut Danchaivijitr, Thanyanan Reungwetwattana, Busayamas Chewaskulyong, Luangyot Thongthieang, Jarin Chindaprasirt, Kunlatida Maneenil, Chirawadee Sathitruangsak, Chanida Vinayanuwattikun. Front Oncol 2021
2

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
Michael J Grant, Roy S Herbst, Sarah B Goldberg. Nat Rev Clin Oncol 2021
2

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis.
Giorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, Luc Friboulet, Francesco Facchinetti. Transl Lung Cancer Res 2021
1

Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Kiyotaka Yoh, Shingo Matsumoto, Naoki Furuya, Kazumi Nishino, Shingo Miyamoto, Satoshi Oizumi, Norio Okamoto, Hidetoshi Itani, Shoichi Kuyama, Atsushi Nakamura,[...]. Lung Cancer 2021
0

Clinical Efficacy and Future Prospects of Immunotherapy in Lung Cancer.
Tomonari Kinoshita, Hideki Terai, Tomonori Yaguchi. Life (Basel) 2021
0

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC).
Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, Arin Nam, Martin Sattler. Cell Rep Med 2021
3

Bioinformatics prediction of differential miRNAs in non-small cell lung cancer.
Kui Xiao, Shenggang Liu, Yijia Xiao, Yang Wang, Zhiruo Zhu, Yaohui Wang, De Tong, Jiehan Jiang. PLoS One 2021
0